1. Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective. Issue 2 (23rd January 2017) Authors: Anton, R; Haas, M; Arlett, P; Weise, M; Balabanov, P; Mazzaglia, G; Prieto, L; Keller‐Stanislawski, B; Raine, J Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Strategy in Regulatory Decision‐Making for Management of Progressive Multifocal Leukoencephalopathy. Issue 5 (11th September 2015) Authors: Segec, A; Keller‐Stanislawski, B; Vermeer, NS; Macchiarulo, C; Straus, SM; Hidalgo‐Simon, A; De Bruin, ML Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 5(2015:Nov.) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗